This invention discloses a pharmaceutical composition for treating chapped
skin caused by tinea pedis and manuum. The composition comprises
urea,
olive leaf extract, oat alkaloids, and asiaticoside as active ingredients, combined with a
hypoallergenic liquid crystal emulsion matrix consisting of
shea butter,
squalane, caprylic /
capric triglycerides, and
cetearyl glucoside. This invention utilizes
urea to soften
keratin and promote crack healing, while simultaneously inhibiting the
irritation caused by
urea through the synergistic effect of three
plant-based anti-inflammatory components, and combining biomimetic oils to repair the
skin's lipid barrier. This composition significantly reduces pain and
itching at the chapped areas in patients with tinea pedis and manuum, promotes
crack closure, and avoids the burning and
irritation commonly found in traditional
antifungal ointments.